PTEN is the most frequently mutated gene in prostate cancer, loss of heterozygosity at 10q23 can be detected in approximately 50% of human prostate cancers, whereas homozygous deletions of PTEN can be detected in approximately 10% of these cases [31]. This evidence concerns the gene PTEN and Familial prostate cancer.